Weekly Update of Drug News-29/10/2025

Updated on: October 29,2025 0

Weekly Update of Drug News-29/10/2025

Updated on:October 29,2025 0

De-escalating DAPT to ticagrelor monotherapy cuts bleeding risk in acute coronary syndrome

Updated on: March 28,2025 0

De-escalating DAPT to ticagrelor monotherapy cuts bleeding risk in acute coronary syndrome

Updated on:March 28,2025 0

2000 to 2021 saw increase in incidence of pancreatic adenocarcinoma

Updated on: May 21,2025 0

2000 to 2021 saw increase in incidence of pancreatic adenocarcinoma

Updated on:May 21,2025 0

Study reveals activity of navtemadlin in glioblastoma, points to possible treatment improvements

Updated on: March 28,2025 0

Study reveals activity of navtemadlin in glioblastoma, points to possible treatment improvements

Updated on:March 28,2025 0

Study yields unexpected results from empagliflozin after heart attack

Updated on: March 28,2025 0

Study yields unexpected results from empagliflozin after heart attack

Updated on:March 28,2025 0

Rescued by fat bubbles: Scientists treat rare genetic disease with designer molecule

Updated on: August 09,2025 0

Rescued by fat bubbles: Scientists treat rare genetic disease with designer molecule

Updated on:August 09,2025 0

Study shows how neurofilaments act like Velcro to clog up brain functions

Updated on: April 18,2025 0

Study shows how neurofilaments act like Velcro to clog up brain functions

Updated on:April 18,2025 0

Regular chicken consumption linked to higher risk of early death from gastrointestinal cancers

Updated on: May 20,2025 0

Regular chicken consumption linked to higher risk of early death from gastrointestinal cancers

Updated on:May 20,2025 0

Cancer cells exploit alternative pathway to gather antioxidant lipids and evade cell death

Updated on: July 15,2025 0

Cancer cells exploit alternative pathway to gather antioxidant lipids and evade cell death

Updated on:July 15,2025 0

DeLLphi-303 Phase Ib trial results demonstrate acceptable safety profile, unprecedented survival in ES-SCLC

Updated on: September 29,2025 0

DeLLphi-303 Phase Ib trial results demonstrate acceptable safety profile, unprecedented survival in ES-SCLC

Updated on:September 29,2025 0